These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8406897)

  • 1. Effect of cholera toxin on vaccine-induced immunity and infection in murine schistosomiasis mansoni.
    Akhiani AA; Nilsson LA; Ouchterlony O
    Infect Immun; 1993 Nov; 61(11):4919-24. PubMed ID: 8406897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological cross reactivity between Schistosoma mansoni and cholera toxin.
    Akhiani AA; Nilsson LA; Ouchterlony O
    Parasite Immunol; 1997 Aug; 19(8):355-61. PubMed ID: 9292894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.
    Pearce EJ; James SL; Hieny S; Lanar DE; Sher A
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5678-82. PubMed ID: 3135553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts.
    James SL; Pearce EJ; Sher A
    J Immunol; 1985 May; 134(5):3432-8. PubMed ID: 3980998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-induced immunity in mice against Schistosoma mansoni trickle cercarial infections.
    Lewis FA; Kennell CJ; James SL
    Am J Trop Med Hyg; 1987 Jul; 37(1):98-105. PubMed ID: 3111284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schistosoma mansoni: IgG reactivity to soluble adult worm antigen preparation (SWAP) in sera of immunized mice with irradiated attenuated and virulent cercariae.
    Hanna LS; Mohamed MI; Botros SS
    J Egypt Soc Parasitol; 1994 Dec; 24(3):553-68. PubMed ID: 7844419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Schistosoma mansoni cyclophilin A epitope 107-121 induces a protective immune response against schistosomiasis.
    de Melo TT; Mendes MM; Alves CC; Carvalho GB; Fernandes VC; Pimenta DLF; de Moraes Mourão M; Gai F; Kalli M; Coelho A; de Azambuja Ribeiro RIM; Falcone FH; Pereira RADS; Fonseca CT
    Mol Immunol; 2019 Jul; 111():172-181. PubMed ID: 31063938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection.
    Martins VP; Pinheiro CS; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Azevedo V; Castro-Borges W; Wilson RA; Oliveira SC
    Clin Dev Immunol; 2012; 2012():962538. PubMed ID: 22927873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
    Farah IO; Johansson M; Lövgren-Bengtson K; Hau J
    Scand J Immunol; 2000 Mar; 51(3):237-43. PubMed ID: 10736092
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
    Front Immunol; 2018; 9():1762. PubMed ID: 30105029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protective immunity and modulation of granulomatous hypersensitivity in mice using PIII, an anionic fraction of Schistosoma mansoni adult worm.
    Hirsch C; Zouain CS; Alves JB; Goes AM
    Parasitology; 1997 Jul; 115 ( Pt 1)():21-8. PubMed ID: 9280892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of adult worm and lung-stage antigens to immunize against Schistosoma mansoni using cytokines as adjuvants.
    Afifi MA; El-Wakil HS; Abdel-Ghaffar MM; Mohamed RT
    J Egypt Soc Parasitol; 2006 Apr; 36(1):351-62, 2p following 362. PubMed ID: 16605124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of adjuvant on induction of protective immunity by a non-living vaccine against schistosomiasis.
    James SL; Pearce EJ
    J Immunol; 1988 Apr; 140(8):2753-9. PubMed ID: 3128608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
    Cardoso FC; Macedo GC; Gava E; Kitten GT; Mati VL; de Melo AL; Caliari MV; Almeida GT; Venancio TM; Verjovski-Almeida S; Oliveira SC
    PLoS Negl Trop Dis; 2008 Oct; 2(10):e308. PubMed ID: 18827884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-12 as an adjuvant for an antischistosome vaccine consisting of adult worm antigens: protection of rats from cercarial challenge.
    Bungiro RD; Goldberg M; Suri PK; Knopf PM
    Infect Immun; 1999 May; 67(5):2340-8. PubMed ID: 10225893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 vaccine-specific responses induced by Listeria vector vaccines are maintained in mice subsequently infected with a model helminth parasite, Schistosoma mansoni.
    Shollenberger LM; Bui CT; Paterson Y; Nyhoff L; Harn DA
    Vaccine; 2013 Nov; 31(48):5651-8. PubMed ID: 24120546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of recombinant protein r140, a polypeptide segment of tegumental glycoprotein Sm25, as a defined antigen vaccine against Schistosoma mansoni.
    Suri PK; Goldberg M; Madikizela M; Petzke MM; Bungiro RD; Davies SJ; Chakraborty B; Nguyen KB; McCray JW; Knopf PM
    Parasite Immunol; 1997 Nov; 19(11):515-29. PubMed ID: 9427998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection.
    Da'Dara AA; Skelly PJ; Walker CM; Harn DA
    Parasite Immunol; 2003; 25(8-9):429-37. PubMed ID: 14651590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of mice with crude extract of Saccharomyces boulardii yeast induces cross-reactive immune responses with antigenic preparations from different developmental stages of the Schistosoma mansoni and reduces the parasite worm burden.
    Bahgat M; Maghraby AS; Ab Del-Fatah OM; Elshafei AM
    J Egypt Soc Parasitol; 2005 Aug; 35(2):563-80. PubMed ID: 16083068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of protective immunity against Schistosoma mansoni by a non-living vaccine. V. Effects of varying the immunization and infection schedule and site.
    James SL
    Parasite Immunol; 1987 Sep; 9(5):531-41. PubMed ID: 3120134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.